TherapeuticsMD Inc (USD)
TXMD
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.38 | 1.49
52-Wk Range- | -
Last Close1.41
Mkt Cap (m)383.94
Dividend yield-
ISINUS88338N1072
Volume4,491,164.00
Exchange VenueNAS

Company Profile

TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales5.90
P/CF-
Rev Growth (3 year avg)36.88
EPS Growth (3 year avg)-
Operating Margin % -304.56
Net Margin %-354.80
Return on Equity-330.09
Debt/Equity22.31

Documents

Prospectus
en 25/10/2019
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.therapeuticsmd.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)15.0320.1419.3616.7816.1049.65
Operating Income (m)-54.04-85.19-90.25-77.63-130.22-151.21
Net Income (m)-54.22-85.08-89.88-76.93-132.62-176.14
Basic EPS-0.36-0.49-0.46-0.37-0.59-0.72
Avg. Diluted Shares Outstanding (m)149.73173.17196.09205.52225.03246.35
Balance Sheet
USD201420152016201720182019
Current Assets (m)56.2470.68139.41139.55186.78208.42
Non Current Assets (m)2.843.053.063.6825.2057.57
Total Assets (m)59.0873.73142.47143.23211.98265.99
Current Liabilities (m)10.6910.6714.9813.3241.0853.00
Total Liabilities (m)------
Total Equity (m)48.3963.06127.49129.9197.529.20
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-45.52-79.04-69.14-76.16-106.81-165.70
Capital Expenditure (m)-0.62-0.58-1.24-0.83-21.32-23.89
Figures are quoted in USD unless stated otherwise
-
No change
$
1.41
Last Price